IGF2BP2 and thyroid gland carcinoma: To identify direct IGF2BP2 targets in thyroid cancer, we performed RIP-seq in TPC1 cells, revealing 3377 binding peaks across 1739 genes, predominantly localized near transcription termination sites (TES).